AU454533B2 - Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof - Google Patents

Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof

Info

Publication number
AU454533B2
AU454533B2 AU33849/71A AU3384971A AU454533B2 AU 454533 B2 AU454533 B2 AU 454533B2 AU 33849/71 A AU33849/71 A AU 33849/71A AU 3384971 A AU3384971 A AU 3384971A AU 454533 B2 AU454533 B2 AU 454533B2
Authority
AU
Australia
Prior art keywords
spirox
animals
ones
derivatives
growth promotion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU33849/71A
Other languages
English (en)
Other versions
AU3384971A (en
Inventor
JEAN PATANELLI and GLEN EDWARD AETH DOLORES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3384971A publication Critical patent/AU3384971A/en
Application granted granted Critical
Publication of AU454533B2 publication Critical patent/AU454533B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU33849/71A 1970-10-06 1971-09-23 Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof Expired AU454533B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7863670A 1970-10-06 1970-10-06
USUS78636 1970-10-06

Publications (2)

Publication Number Publication Date
AU3384971A AU3384971A (en) 1973-03-29
AU454533B2 true AU454533B2 (en) 1974-10-31

Family

ID=22145320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33849/71A Expired AU454533B2 (en) 1970-10-06 1971-09-23 Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof

Country Status (6)

Country Link
US (1) US3670079A (https=)
AU (1) AU454533B2 (https=)
CA (1) CA968710A (https=)
DE (1) DE2149744A1 (https=)
FR (1) FR2110251B1 (https=)
GB (1) GB1350114A (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013762A (en) * 1976-05-10 1977-03-22 Richardson-Merrell Inc. Growth promotion
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
IL152771A0 (en) * 2000-06-26 2003-06-24 Pfizer Prod Inc PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
US6849638B2 (en) * 2001-04-30 2005-02-01 Bayer Pharmaceuticals Corporation 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
JP4884570B2 (ja) 2008-08-20 2012-02-29 ファイザー・インク ピロロ［２，３−ｄ］ピリミジン化合物
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254074A (en) * 1962-04-25 1966-05-31 Merck & Co Inc Spiroxenones

Also Published As

Publication number Publication date
FR2110251A1 (https=) 1972-06-02
GB1350114A (en) 1974-04-18
US3670079A (en) 1972-06-13
AU3384971A (en) 1973-03-29
DE2149744A1 (de) 1972-04-13
FR2110251B1 (https=) 1975-06-06
CA968710A (en) 1975-06-03

Similar Documents

Publication Publication Date Title
AU454533B2 (en) Growth promotion in animals by using 1-nor-20-spirox-4-en-3 ones and derivatives thereof
AU3200771A (en) Interferon induction in animals by amines
CA927860A (en) Toy animal
AU465597B2 (en) Azetidinane derivatives and their preparation
CA919592A (en) Methods and preparations for obtaining diureses in animals including man
CA927661A (en) Guanidines employed in animal husbandry
AU1731270A (en) Improvements in or relating to animal traps
AU431569B2 (en) Improvements in and relating to animal milkin apparatus
CA842841A (en) 6-diloweralkylamino-fluoran derivatives and their preparation and use
CA847314A (en) Methods and compositions for use in animal husbandry
AU458339B2 (en) Methods and preparations for obtaining diuresis in animals, including man
AU2808671A (en) Improvements in and relating to animal milkin apparatus
AU466898B1 (en) Improvement in ground augers
AU453864B2 (en) Improvements in and relating to conveyors
CA867336A (en) Methods and compositions in animal husbandry
CA838660A (en) Animal repellent composition and methods
AU440491B2 (en) Improvements in and relating to the branding of animals
AU3345671A (en) Improvements in and relating tostone pickers
AU2704471A (en) Methods and preparations for obtaining diuresis in animals, including man
AU455055B2 (en) Improvements in transistorized amplifiers
CA950286A (en) Apparatus for raising and harvesting fish
AU3732771A (en) Improvements in and relating to conveyors
CA856818A (en) 4-phenyl-8-amino-isoquinoline and derivatives thereof
CA852411A (en) Crop stores and silos
AU455287B2 (en) Indolazonine and indolazecine derivatives